GSK has seen nearly £7bn wiped off its value after a US court ruled that over 70,000 lawsuits against the British pharmaceutical company could proceed.
GSK has seen nearly £7bn wiped off its value after a US court ruled that over 70,000 lawsuits against the British pharmaceutical company could proceed.